Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation

The FDA Office of Women's Health in collaboration with CDER’s Division of Pediatrics and Maternal Health hosted a follow-up webinar on October 27, 2022 titled: Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation. This presentation aimed to build on a previous discussion about the FDA’s current pregnancy and lactation labeling system, also known as the Pregnancy and Lactation Labeling Rule (PLLR).
Although the PLLR improved the presentation of information in prescription medication labeling, it highlighted the gaps in human data for medications used during pregnancy and lactation. This presentation provided an overview of the studies enrolling pregnant and lactating individuals, the work FDA is doing to advance research in pregnant and lactating individuals, and information on how providers can become involved in advancing research in pregnant and lactating individuals.
Learn more: www.fda.gov/co...